NUSCO SPA (NUS.MI) Stock Fundamental Analysis

BIT:NUS • IT0005453110

0.695 EUR
-0.04 (-5.44%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Taking everything into account, NUS scores 2 out of 10 in our fundamental rating. NUS was compared to 21 industry peers in the Building Products industry. NUS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NUS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • NUS had negative earnings in the past year.
  • In the past year NUS had a positive cash flow from operations.
  • NUS had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: NUS reported negative operating cash flow in multiple years.
NUS.MI Yearly Net Income VS EBIT VS OCF VS FCFNUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.28%, NUS is doing worse than 95.24% of the companies in the same industry.
  • The Return On Equity of NUS (-2.96%) is worse than 90.48% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.68%, NUS is doing worse than 90.48% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NUS is below the industry average of 8.96%.
Industry RankSector Rank
ROA -1.28%
ROE -2.96%
ROIC 1.68%
ROA(3y)2.31%
ROA(5y)1.38%
ROE(3y)5.41%
ROE(5y)3.13%
ROIC(3y)5.35%
ROIC(5y)4.03%
NUS.MI Yearly ROA, ROE, ROICNUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

  • In the last couple of years the Profit Margin of NUS has grown nicely.
  • NUS has a Operating Margin of 2.27%. This is amonst the worse of the industry: NUS underperforms 90.48% of its industry peers.
  • NUS's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 40.90%, NUS perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NUS has declined.
Industry RankSector Rank
OM 2.27%
PM (TTM) N/A
GM 40.9%
OM growth 3Y5.79%
OM growth 5Y-4.26%
PM growth 3Y9.01%
PM growth 5Y9.59%
GM growth 3Y7.06%
GM growth 5Y-2.06%
NUS.MI Yearly Profit, Operating, Gross MarginsNUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • NUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NUS remains at a similar level compared to 1 year ago.
  • NUS has more shares outstanding than it did 5 years ago.
  • NUS has a better debt/assets ratio than last year.
NUS.MI Yearly Shares OutstandingNUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NUS.MI Yearly Total Debt VS Total AssetsNUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 1.44, we must say that NUS is in the distress zone and has some risk of bankruptcy.
  • NUS's Altman-Z score of 1.44 is on the low side compared to the rest of the industry. NUS is outperformed by 85.71% of its industry peers.
  • A Debt/Equity ratio of 0.24 indicates that NUS is not too dependend on debt financing.
  • NUS's Debt to Equity ratio of 0.24 is amongst the best of the industry. NUS outperforms 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 1.44
ROIC/WACC0.26
WACC6.42%
NUS.MI Yearly LT Debt VS Equity VS FCFNUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

2.3 Liquidity

  • NUS has a Current Ratio of 1.67. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
  • NUS's Current ratio of 1.67 is fine compared to the rest of the industry. NUS outperforms 66.67% of its industry peers.
  • A Quick Ratio of 1.17 indicates that NUS should not have too much problems paying its short term obligations.
  • NUS has a Quick ratio of 1.17. This is in the better half of the industry: NUS outperforms 76.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.17
NUS.MI Yearly Current Assets VS Current LiabilitesNUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for NUS have decreased strongly by -128.88% in the last year.
  • Measured over the past years, NUS shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.44% on average per year.
  • NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.48%.
  • The Revenue has been growing by 21.43% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-128.88%
EPS 3Y28.29%
EPS 5Y24.44%
EPS Q2Q%-116.98%
Revenue 1Y (TTM)-15.48%
Revenue growth 3Y27.23%
Revenue growth 5Y21.43%
Sales Q2Q%-6.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUS.MI Yearly Revenue VS EstimatesNUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NUS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUS.MI Price Earnings VS Forward Price EarningsNUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as NUS.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8
NUS.MI Per share dataNUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NUS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NUSCO SPA

BIT:NUS (2/27/2026, 7:00:00 PM)

0.695

-0.04 (-5.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.71%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.87M
Revenue(TTM)49.52M
Net Income(TTM)-791.70K
Analysts80
Price Target2.24 (222.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF 5.74
P/B 0.52
P/tB 0.63
EV/EBITDA 8
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.12
OCFY17.42%
SpS2.48
BVpS1.34
TBVpS1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.28%
ROE -2.96%
ROCE 3.12%
ROIC 1.68%
ROICexc 1.74%
ROICexgc 2.03%
OM 2.27%
PM (TTM) N/A
GM 40.9%
FCFM N/A
ROA(3y)2.31%
ROA(5y)1.38%
ROE(3y)5.41%
ROE(5y)3.13%
ROIC(3y)5.35%
ROIC(5y)4.03%
ROICexc(3y)5.81%
ROICexc(5y)4.37%
ROICexgc(3y)7.26%
ROICexgc(5y)5.4%
ROCE(3y)9.93%
ROCE(5y)7.49%
ROICexgc growth 3Y19.53%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y18.73%
ROICexc growth 5Y1.56%
OM growth 3Y5.79%
OM growth 5Y-4.26%
PM growth 3Y9.01%
PM growth 5Y9.59%
GM growth 3Y7.06%
GM growth 5Y-2.06%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 2.05
Cap/Depr 279.96%
Cap/Sales 11.12%
Interest Coverage 250
Cash Conversion 78.11%
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.17
Altman-Z 1.44
F-Score4
WACC6.42%
ROIC/WACC0.26
Cap/Depr(3y)426.48%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.45%
Cap/Sales(5y)19.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.88%
EPS 3Y28.29%
EPS 5Y24.44%
EPS Q2Q%-116.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.48%
Revenue growth 3Y27.23%
Revenue growth 5Y21.43%
Sales Q2Q%-6.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-79.02%
EBIT growth 3Y34.59%
EBIT growth 5Y16.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y89.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.48%
OCF growth 3YN/A
OCF growth 5YN/A

NUSCO SPA / NUS.MI FAQ

Can you provide the ChartMill fundamental rating for NUSCO SPA?

ChartMill assigns a fundamental rating of 2 / 10 to NUS.MI.


What is the valuation status of NUSCO SPA (NUS.MI) stock?

ChartMill assigns a valuation rating of 0 / 10 to NUSCO SPA (NUS.MI). This can be considered as Overvalued.


How profitable is NUSCO SPA (NUS.MI) stock?

NUSCO SPA (NUS.MI) has a profitability rating of 2 / 10.